Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

818990

	registered interest
	date	09/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will consider the merits of introducing a national audit system for clinical trials; and if he will make a statement.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	121667
	answer	answer is ministerial correction date of answer 17/01/2018 answer text <p><strong></strong>All clinical trials of investigational medicinal products in the European Union are registered and information on the trial and a summary of results is made public in the EU clinical trials register, except for adult phase 1 trials which are considered commercially confidential.</p><p> </p><p>Good clinical practice (GCP) is a set of internationally-recognised ethical and scientific quality requirements that must be followed when designing, conducting, recording and reporting clinical trials that involve people. To ensure compliance with GCP, the Medicines and Healthcare products Regulatory Agency carries out inspections in the United Kingdom of organisations that are involved in clinical trials.</p><p> </p><p>The Government’s National Institute for Health Research (NIHR) which is the country’s largest public funder of health research and trials, has implemented a number of initiatives on publication of research results. The NIHR is the world’s first health research funder to publish comprehensive accounts of its commissioned research within its own publicly and permanently available journal series. The NIHR Journals Library comprises a suite of five open access peer-reviewed journals reporting results from a range of health research areas. The reports provide a full account of the research project, including methods and a full description of the results, and complement shorter articles submitted for publication in other peer-review journals, which the NIHR actively encourages researchers to do as part of their dissemination strategy. In addition – contracts for NIHR funding include requirements on publication of the results from NIHR funded and supported research.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 17/01/2018 14:41:19 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4433 label Biography information for Thangam Debbonaire

847742

	registered interest
	date	23/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Prisoners
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the (a) availability, (b) quality and (c) effectiveness of HIV testing and treatment in prisons.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	129418
	answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>HIV testing is available in all prisons in England through healthcare services commissioned by NHS England, through both primary care and genitourinary medicine services. Additionally, all adult prisons in England will provide HIV testing through an ‘opt-out’ testing programme at or near reception by the end of the current financial year as part of a wider blood-borne virus opt-out testing programme being delivered in partnership between Public Health England, NHS England and Her Majesty’s Prison and Probation Service.</p><p> </p><p>The quality of services is assessed by NHS England on a quarterly basis through the collection of data via the Health and Justice Indicators of Performance (HJIPs), which includes information on the number of people offered HIV tests, those tested and the number of people newly diagnosed with HIV referred for treatment within two weeks of diagnosis.</p><p> </p><p>For quarter one of financial year 2017/18, 10,574 prisoners were tested for HIV, and 197 cases of HIV were diagnosed in this cohort. Of those, 39 were seen by specialist service providers within two weeks of diagnosis. Further information is available here:</p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/666850/BBV_bulletin_Dec_2017.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/666850/BBV_bulletin_Dec_2017.pdf</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/03/2018 14:27:53 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4433 label Biography information for Thangam Debbonaire

847743

	registered interest
	date	23/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Prisons
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the (a) quality, (b) availability and (c) effectiveness of drug treatment services in prisons.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	129419
	answer	answer is ministerial correction date of answer 05/03/2018 answer text <p>Drug treatment services in prisons have been systematically reviewed over the past 18 months, as a part of the development of a new service specification. NHS England and their partners support development of a new commissioning service specification as part of a quality improvement programme for prison health services. The NHS England teams that commission these assessments also hold quarterly performance review meetings with drug treatment providers, and recommission the services as a part of a three to five year cycle (or earlier if required).</p><p> </p><p>On average, there was no wait for drug treatment services and nearly all (95%) people started their first treatment intervention within three weeks of being assessed but would start immediately if it was clinically appropriate to do so. Regular needs assessments are undertaken by NHS England to identify specific establishment-level needs.</p><p> </p><p>Effectiveness is measured by Public Health England through the National Drug Treatment Monitoring System. In total, 37,330 individuals left treatment between 1 April 2016 and 31 March 2017. Of the individuals that left treatment in the year, 10,066 (27%) were discharged as ‘treatment completed’, up from 23% in 2015-16. Further information is available here:</p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/677500/OFFICIAL-SENSITIVE_secure_setting_annual_report_2016-17FINAL-v1.2.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/677500/OFFICIAL-SENSITIVE_secure_setting_annual_report_2016-17FINAL-v1.2.pdf</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 05/03/2018 14:29:11 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4433 label Biography information for Thangam Debbonaire

805102

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Rare Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health what steps his Department is taking to ensure that researchers in the UK can continue to access pan-EU patient cohorts for rare disease and other special populations after the UK has withdrawn from the EU; and if he will make a statement.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	118774
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>The Government's policy paper, Collaboration on Science and Innovation: A Future Partnership Paper, emphasises the importance of continued collaboration with European partners to ensure that the United Kingdom remains one of the best places in the world for science and innovation. European Reference Networks for rare diseases were cited in the paper as an example of a partnership that the UK believes should continue.</p><p> </p><p>A key principle for the Government is that patients should not be put at a disadvantage as a result of European Union-exit.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/12/2017 11:50:56 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4433 label Biography information for Thangam Debbonaire